Investigation of Heart and Vascular Outcomes in Older Veterans
老年退伍军人心脏和血管结局的调查
基本信息
- 批准号:10618301
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgeAge FactorsAge YearsAlcohol consumptionAlgorithmsAmbulatory CareAmericanAmerican Heart AssociationAortic Valve StenosisAssessment toolAtherosclerosisAtrial FibrillationBiological AssayBiological MarkersBlack PopulationsBloodBlood CellsBlood PressureBlood VesselsBody mass indexCalendarCardiologyCardiovascular DiseasesCardiovascular systemCause of DeathCessation of lifeChronic DiseaseChronic Kidney FailureClassificationCodeComplexCountyDataData SourcesDatabasesDevelopmentDiabetes MellitusDiagnosisDiagnosticDiseaseDisease OutcomeEFRACElderlyElectronic Health RecordEquationErythrocyte IndicesEthnic OriginEvaluationEventFormulationFundingGlomerular Filtration RateGlucoseGlycosylated hemoglobin AHealth care facilityHeartHeart DiseasesHeart failureHemoglobinHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHispanic PopulationsHospitalizationICD-9IncidenceInsuranceInvestigationLDL Cholesterol LipoproteinsLaboratoriesLength of StayLeukocytesLinkLipidsMapsMeasurementMeasuresMediationMedicalModelingModernizationMyocardial InfarctionNon-Insulin-Dependent Diabetes MellitusObstructive Sleep ApneaOutcomeOutpatientsPharmaceutical PreparationsPhenotypePopulationPreventivePreventive therapyProductivityPrognosisProgress ReportsPublishingRaceRecurrenceRenal functionReportingResearchResearch PersonnelRiskRisk AssessmentRisk EstimateRisk FactorsRoleSerum AlbuminStrokeTestingThyrotropinTimeUnited StatesUnited States Centers for Medicare and Medicaid ServicesUnited States Department of Veterans AffairsValidationVascular DiseasesVeteransVeterans Health AdministrationVisitVisualizationWhite Blood Cell Count procedurealcohol use disorderaortic valve replacementcardiovascular disorder riskcardiovascular risk factorcigarette smokingcohortcollegedata curationdata modelingdisease prognosisexperiencefollow-upfrailtyhospital laboratorieshospital readmissionindexinginnovationinterestlifestyle factorslipoprotein cholesterolmalemortalitymultimodalitynovelprediction algorithmpreservationprospectiverisk predictionsexstroke risksuburbvenous thromboembolismvirtual
项目摘要
The objective of this project is to utilize a longitudinal, VA national cardiovascular disease virtual cohort
to investigate traditional, and [new] risk factors (RFs), for Heart Failure (HF), Atrial Fibrillation (AF), and stroke
among United States Veterans ≥ 65. This cohort will consist of contemporary and comprehensive electronic
health record (EHR) data and will include continued curation and validation of complex phenotypes using
innovative analytics. [The specific aims of this research in older Veterans are to: 1) Assess determinants of HF
risk and prognosis after HF diagnosis in a VA Healthcare facility, 2), Assess determinants of AF risk and
prognosis and 3) Assess determinants of Stroke risk and prognosis.]
[During the previous funding cycle, we leveraged the VA’s large scale national longitudinal EHR data,
linked to additional data sources including the Centers for Medicare and Medicaid Services (CMS) and the
National Death Index (NDI) to create a comprehensive cardiovascular database. Data curation for traditional
RFs, ASCVD preventive therapies, and several ASCVD outcomes was also completed in the previous funding
cycle. Our new proposal will include continued data curation to include novel RFs, such as red cell indices,
white blood cell indices, obstructive sleep apnea, frailty, alcohol intake, aortic stenosis, medication use, lifestyle
factors, and blood measures [estimated glomerular filtration rate (eGFR), serum albumin]. We will achieve this
by employing high-throughput probabilistic phenotyping and multimodal and network data modeling. Outcomes
and risk factors will be evaluated over time where appropriate.]
Electronic health record (EHR) data will be used to identify a baseline index date for Veterans based on
an outpatient VAMC visit at which time the Veteran had blood assayed for traditional lipids. Information from
the baseline and follow up visits will be obtained with database programming and will include: age, sex, systolic
BP, diabetes status, cholesterol, HDL-C, TG, and CVD preventive medications. Filtering algorithms will be
used for laboratory measures across the different hospital laboratories, as has already been undertaken by this
research team. Similarly, BMI, glucose and hemoglobin A1c (HbA1c) measurements, and vascular disease
ICD-9/10 codes will be added.
[Incidence and prognosis of HF, AF, and stroke will assess the role of established and novel risk
profiles. Outcomes to be analyzed include myocardial infarction, stroke, cardiovascular mortality, and all-cause
mortality. For HF we will also examine HF hospital admissions and HF re-admissions within 30 days of
diagnosis. We will compare currently published algorithms for the three conditions where appropriate and
compare the results to our own developed regression models that include novel RFs using mediation analyses
and reclassification strategies where appropriate. We will also report county- specific mapping of outcomes.]
该项目的目的是利用纵向VA国家心血管疾病虚拟队列
研究传统和[新的]风险因素(RFS),用于心力衰竭(HF),房颤(AF)和中风
在美国退伍军人≥65中。该队列将包括现代和全面的电子
健康记录(EHR)数据,并将包括持续的策划和使用复杂表型的验证
创新分析。 [这项研究在老年退伍军人中的具体目的是:1)评估HF的确定词
在VA医疗机构中HF诊断后的风险和提示,2),评估AF风险和
预后和3)评估中风风险和预后的决定者。]
[在上一个基础周期中,我们利用VA的大规模国家纵向EHR数据,
链接到其他数据来源,包括医疗保险和医疗补助服务中心(CMS)和
国家死亡指数(NDI)创建一个全面的心血管数据库。传统的数据策划
RFS,ASCVD预防疗法和以前的资金也完成了几个ASCVD结果
循环。我们的新建议将包括持续的数据策划,包括新的RF,例如红细胞指数,
白细胞指数,阻塞性睡眠呼吸暂停,脆弱,酒精摄入量,主动脉狭窄,药物使用,生活方式
因素和血液测量[估计的肾小球过滤率(EGFR),血清白蛋白]。我们将实现这一目标
通过采用高通量概率表型,多模式和网络数据建模。结果
在适当的情况下,随着时间的推移将评估风险因素。
电子健康记录(EHR)数据将用于确定基于退伍军人的基线指数日期
在那个时候,老兵将鲜血分配给传统脂质的情况。来自
基线和后续访问将通过数据库编程获得,其中包括:年龄,性别,收缩期
BP,糖尿病状态,胆固醇,HDL-C,TG和CVD预防药物。过滤算法将是
正如这已经进行的,用于不同医院实验室的实验室措施
研究团队。同样,BMI,葡萄糖和血红蛋白A1C(HBA1C)测量和血管疾病
将添加ICD-9/10代码。
[HF,AF和中风的发病率和预后将评估已建立和新型风险的作用
概况。要分析的结果包括心肌梗塞,中风,心血管死亡率和全因
死亡。对于HF,我们还将检查HF医院入院和HF重新入院
诊断。我们将在适当的情况下比较当前发布的三种条件算法
将结果与我们自己开发的回归模型进行比较,该模型包括使用中介分析的新型RF
并在适当的地方进行重新分类策略。我们还将报告县的结果。]
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly Cho其他文献
Kelly Cho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly Cho', 18)}}的其他基金
Investigation of Heart and Vascular Outcomes in Older Veterans
老年退伍军人心脏和血管结局的调查
- 批准号:
10426071 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Cardiovascular Disease Risk Factors, Prevalent Cardiovascular Disease, and Genetics in the Million Veteran Program
百万退伍军人计划中的心血管疾病危险因素、流行的心血管疾病和遗传学
- 批准号:
9031899 - 财政年份:2016
- 资助金额:
-- - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
-- - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
-- - 项目类别: